{"DataElement":{"publicId":"2787876","version":"1","preferredName":"Other Pharmacologic Substance Administered Specify Text","preferredDefinition":"The free-text field to describe another agent that was administered.","longName":"OTH_PHSUB_ADMIN_SPC","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2787852","version":"1","preferredName":"Other Pharmacologic Substance Administered","preferredDefinition":"Different than the one(s) previously specified or mentioned._An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b))._The act of having given something (e.g., a medication or test).","longName":"OTH_PHRMSUB_ADMIN","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2862167","version":"1","preferredName":"Other Pharmacologic Substance","preferredDefinition":"Not otherwise specified.:A natural, synthetic or semi-synthetic substance including endogenous body substance used to diagnose, prevent, maintain, treat or analyze abnormal and normal biological functions in vivo or in vitro.","longName":"C17649:C1909","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacologic Substance","conceptCode":"C1909","definition":"Any natural, endogenously-derived, synthetic or semi-synthetic compound with pharmacologic activity. A pharmacologic substance has one or more specific mechanism of action(s) through which it exerts one or more effect(s) on the human or animal body. They can be used to potentially prevent, diagnose, treat or relieve symptoms of a disease. Formulation specific agents and some combination agents are also classified as pharmacologic substances.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6827164E-9700-4853-E040-BB89AD433E50","latestVersionIndicator":"Yes","beginDate":"2009-04-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-04-22","modifiedBy":"ONEDATA","dateModified":"2009-04-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57BF2442-B553-6834-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-25","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2799057","version":"1","preferredName":"Specify Text","preferredDefinition":"Be specific about something; define clearly._Text; the words of something written.","longName":"SPC_TXT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2799056","version":"1","preferredName":"Specify Text","preferredDefinition":"Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D89B-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"ONEDATA","dateModified":"2008-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6FE321-D8AC-66BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-11-11","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-11","modifiedBy":"MALUMK","dateModified":"2021-01-19","changeDescription":"03/17/10-Added CSI for F2000-CJL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2842912","version":"1","longName":"Therapy","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2842918","version":"1","longName":"Administration","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cgvhd_trt_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"agvhd_trt_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"agvhd_prevent_othr_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"MaterialName:name","type":"HCT_BRIDG","context":"NHLBI"},{"name":"HPST_GFCT_oth_agent_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_oth_agent_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_oth_agent_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_oth_agent_spec","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the other agent admin","type":"Preferred Question Text","description":"Specify the other agent administered:","url":null,"context":"NHLBI"},{"name":"Specify:","type":"Alternate Question Text","description":"Specify:","url":null,"context":"NHLBI"},{"name":"Specify the other agent used after the start of the preparative regimen to prevent acute GVHD or graft rejection:","type":"Alternate Question Text","description":"Specify the other agent used after the start of the preparative regimen to prevent acute GVHD or graft rejection:","url":null,"context":"NHLBI"},{"name":"Specify other agent","type":"Alternate Question Text","description":"Specify other agent","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2787876","type":"BRIDG Mapping Path","description":"PerformedProcedure > DefinedActivity > Product > MaterialName.name","url":null,"context":"NHLBI"},{"name":"Specify other agent:","type":"Alternate Question Text","description":"Specify other agent:","url":null,"context":"NHLBI"},{"name":"Specify other agent:","type":"Application Standard Question Text","description":"Specify other agent:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57C01BBB-FC9F-5BDF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-25","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-25","modifiedBy":"MALUMK","dateModified":"2021-10-04","changeDescription":". Added human readable def. System generated def displayed as alt def. No version needed. AK 10/7/14 ASQT added for 2100r4. AK 2/24/16. 2/25/16mn-added aqt Specify other agent:. ALT names added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}